The Role of Granulocyte Colony Stimulating Factor in Embryo Transfer Outcomes
Status:
Recruiting
Trial end date:
2025-01-10
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to test the effect of granulocyte colony-stimulating
factor (G-CSF, A.K.A. Filgrastim) in infertility patients undergoing in vitro fertilization
(IVF) treatment. The main question it aims to answer is:
Can in vitro fertilization-embryo transfer (IVF-ET) outcomes be improved by supplementing the
transfer media with Granulocyte colony-stimulating factor (GCSF)?
Participants will undergo their embryo transfer as per the normal clinic protocol but will be
randomized to either receive the standard embryo transfer media or the GCSG-supplemented
transfer media.
Researchers will compare the GCSF and standard transfer media groups to see if clinical
outcomes are improved (i.e., implantation rate, pregnancy, clinical pregnancy rate, live
birth rate).